15.00 -0.16 (-1.07%)
ITMN
Stock Details
Last Trade:15.00 Change:-0.16 (-1.07%) Prev Close:15.16 Open: 15.00 Days Range:14.71 – 15.22 52 Week Range: 8.66 - 20.00 Volume:1590528 P/E: N/AEPS:-2.86
View AllRecent Alerts 07/04/09
Recent Alert on 05/18/09 at 9:17am
UBS Upgrades InterMune (ITMN) to Neutral
UBS Upgrades InterMune (ITMN) to Neutral
UBS upgrades InterMune (Nasdaq: ITMN) from Sell to Neutral. Price target $13. InterMune, Inc. (InterMune) is a biotech company focused on developing and commercializing therapies in pulmonology and hepatology. To see more analyst ratings on ITMN... Read More
Recent Alert on 04/24/09 at 11:02am
InterMune (ITMN) Reports Presentation of Triple Combination Study of ITMN-191 at European Association for the Study of the Liver
InterMune (ITMN) Reports Presentation of Triple Combination Study of ITMN-191 at European Association for the Study of the Liver
Recent Alert on 04/24/09 at 11:02am
InterMune (ITMN) Reports Presentation of Triple Combination Study of ITMN-191 at European Association for the Study of the Liver
InterMune (ITMN) Reports Presentation of Triple Combination Study of ITMN-191 at European Association for the Study of the Liver
View AllRecent Press Releases
No Recent Press Releases Available
View AllRecent SEC Filings
No Recent SEC Filings Available
View AllRecent Blog Posts
Blog Posts on 06/28/09 at 7:47am
30 Possible Pandemic Profit Plays: Bullish Biotech and Drug Stocks to Watch
30 Possible Pandemic Profit Plays: Bullish Biotech and Drug Stocks to Watch
Blog Posts on 06/04/09 at 7:43am
Top Hedge Fund Managers Liquidate: Expect Downward Pressure on Holdings
Top Hedge Fund Managers Liquidate: Expect Downward Pressure on Holdings
Blog Posts on 06/04/09 at 7:43am
Hedge Fund Managers Liquidate: Expect Downward Pressure on Top Holdings
Hedge Fund Managers Liquidate: Expect Downward Pressure on Top Holdings